Clinical Trial Update: Xylometazoline and Cocaine for Nasal Vasoconstriction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing nasal vasoconstriction with xylometazoline and cocaine for epistaxis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epistaxis

Drugs mentioned

• Cocaine (cocaine)
• Xylometazoline (Xylometazoline)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Epistaxis | Phase 4 | Status: COMPLETED